Study summary

A once-weekly insulin with fixed doses worked as well as daily insulin

QWINT-1 trial (weekly insulin efsitora) · 795 people, phase 3 · Published July 2025, New England Journal of Medicine

2dose changes needed in a year, vs 8 with daily glargine (median)

What was tested

Efsitora, a once-weekly basal insulin given at four fixed dose steps, against daily insulin glargine in people starting insulin.

What they found

What it means

Weekly insulin could make starting insulin simpler.

N Engl J Med, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.